{"id":"W2609045359","doi":"10.1016/j.ahj.2017.04.008","title":"Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial","year":2017,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":293,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"Canadian Institutes of Health Research; Novo Nordisk Fonden","keywords":"Medicine; Apixaban; Atrial fibrillation; Cardiology; Internal medicine; Reduction (mathematics); Embolism; Clinical trial; Rivaroxaban; Warfarin","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000831431,0.00008147642,0.0003642132,0.00006263689,0.0002746213,0.0000326181,0.00007776798,0.00003441866,0.000008051903],"category_scores_gemma":[0.0009429552,0.00004437915,0.0001804931,0.0001072945,0.0003542942,0.000138458,0.00002588468,0.000119282,3.278781e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002032851,"about_ca_system_score_gemma":0.0001242937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000034013,"about_ca_topic_score_gemma":0.000006223163,"domain_scores_codex":[0.9987881,0.0001877009,0.0005081879,0.0001121236,0.0002981095,0.000105738],"domain_scores_gemma":[0.9981474,0.0005694755,0.00080885,0.000226461,0.0002070636,0.00004072663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02479679,0.00001267442,0.9603236,0.00001103385,0.0001564856,1.162636e-7,0.0001240311,0.0004709643,0.0003642619,0.00002836344,0.0002772592,0.01343437],"study_design_scores_gemma":[0.02069847,0.001331735,0.9762629,0.00004434341,0.0001978802,0.000005657996,0.00009638963,0.0005409197,0.0001798591,0.00008871858,0.000502166,0.00005098475],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938219,0.00005130544,0.0007144209,0.003218157,0.0004557978,0.001724269,0.000003175553,0.000003960142,0.0000070242],"genre_scores_gemma":[0.9968512,0.0000741089,0.001406357,0.00002682107,0.001604371,0.00000161548,0.0000023914,0.000009971116,0.00002318179],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01593923,"threshold_uncertainty_score":0.2112193,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.107387908043509,"score_gpt":0.3791721058101254,"score_spread":0.2717841977666164,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}